| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 29, 2026 | ±3.5% | -1.2% | over-priced |
| November 26, 2025 | ±4.3% | +3.7% | over-priced |
| August 29, 2025 | ±2.6% | -0.9% | over-priced |
| May 30, 2025 | ±2.9% | -0.9% | over-priced |
| August 30, 2024 | ±2.1% | +0.1% | over-priced |
| May 31, 2024 | ±1.9% | +4.2% | under-priced |
| November 22, 2023 | ±4.7% | -0.2% | over-priced |
| August 25, 2023 | ±2.9% | -1.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | $1.71 | $25.4B | $781M |
| Q4 FY2026 | $2.29 | $30.5B | $1.0B |
| Q3 FY2026 | $1.51 | $25.3B | $689M |
| Q2 FY2026 | $2.05 | $25.2B | $935M |
Target Corporation (TGT) reports in 144 days, with the next report estimated for November 4, 2026. Across the last 8 reports, options priced an average ±3.1% earnings move while the stock actually moved 1.6% on average — the market has systematically over-priced TGT's earnings risk. Fundamentals into the print: EPS down 24.7% year-over-year, revenue up 6.7%. QuantLogix's live 5-factor engine currently reads TGT as a buy at 66/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →